Dr. David M. Plank, MD

Dr. Plank practices at Nola Dermatology in Orlando, Florida.

Dr. Plank's NPI, 1689838559, was assigned on July 10, 2008. Dr. Plank graduated from University Of Cincinnati College Of Medicine in 2007. Dr. Plank holds Florida license ME105111.

Dr. Plank's primary practice is Nola Dermatology, at 7652 Ashley Park Ct Ste 305 Suite 305, Orlando, FL 32835. The practice phone is (407) 299-7333.

Dr. Plank's primary practice is Nola Dermatology in Orlando, Florida. Dr. Plank is also affiliated with Northern Inyo Hospital. The medical group on file is Mid-Florida Dermatology Associates. Dmand AI also links Dr. Plank to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Plank practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Plank's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Plank is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Plank's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists breast reconstruction and cancerous skin growth removal among the conditions Dr. Plank treats.

CMS data shows 774 Medicare services from Dr. Plank across 22 procedure codes in 2024, for 277 Medicare patients. Medicare paid $130,068 for them. Every service was in an office.

CMS counts 277 Medicare patients who saw Dr. Plank in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Plank's median patient age at 61, with 51% women.

In 2024, Dr. Plank wrote 133 Medicare Part D claims for 74 patients. 100% of them were for generic drugs. CMS names the drug for 100 of them, across 5 drugs with 11 or more claims each, at $1,384 in total drug cost. In 2023, CMS named 95 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Plank for performance year 2024, reported individually. Dr. Plank accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 229 procedures of melanoma (skin cancer) excision by Dr. Plank, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Plank, published from 2003 to 2022. The most frequent topics are Calcium, Mice, Transgenic and Cells, Cultured. Dr. Plank has published most often in Circ Res. Dr. Plank's most frequent co-authors are Candace Jordan Glenn, MD, Thomas Charles Hartmann, MD and Karen Lu, MD.

CMS Open Payments shows 30 general payments to Dr. Plank from 8 drug and device companies from 2016 to 2025. Gifts make up the largest share, 53% of the total. Allergan Inc. paid the most, $3,245.

Dr. Plank graduated from University Of Cincinnati College Of Medicine in 2007.

Dr. Plank is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.